Skip to main content

Advertisement

Log in

ADHD genetics: 2007 update

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is highly heritable. Confirmed association has been reported for several candidate genes, including DAT1, DRD4, SNAP-25, DRD5, 5HTT, HTR1B, and DBH; however, these confer relatively small risk. Family-based linkage studies have identified a number of chromosomal regions containing potential ADHD predisposing loci, some overlapping in two or more studies, including 5p, 6q, 7p, 11q, 12q, and 17p. New large-scale studies that apply recent technological advances to perform high-density genotyping of the entire genome, in combination with information on the haplotype structure of the human genome, now allow testing of single-nucleotide polymorphism association with disease phenotype without any a priori hypothesis. They may contribute further to our understanding of the genetic factors involved in ADHD. The heterogeneous complex ADHD phenotype, as well as epigenetic factors may be contributing to the challenge of genetic studies. Samples that include limited age ranges may have better success at uncovering genes whose expression is limited to specific developmental stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Faraone SV, Biederman J, Chen WJ, et al.: Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol 1995, 104:334–345.

    Article  PubMed  CAS  Google Scholar 

  2. Sprich S, Biederman J, Crawford MH, et al.: Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 2000, 39:1432–1437.

    Article  PubMed  CAS  Google Scholar 

  3. Faraone SV, Perlis RH, Doyle AE, et al.: Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313–1323.

    Article  PubMed  CAS  Google Scholar 

  4. Fisher SE, Francks C, McCracken JT, et al.: A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002, 70:1183–1196.

    Article  PubMed  CAS  Google Scholar 

  5. Smalley S, Kustanovich V, Minassian SL, et al.: Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 2002, 71:959–963.

    Article  PubMed  Google Scholar 

  6. Ogdie MN, Macphie IL, Minassian SL, et al.: A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 2003, 72:1268–1279.

    Article  PubMed  CAS  Google Scholar 

  7. Ogdie MN, Fisher SE, Yang M, et al.: Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 2004, 75:661–668.

    Article  PubMed  CAS  Google Scholar 

  8. Bakker SC, van der Meulen EM, Buitelaar JK, et al.: A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 2003, 72:1251–1260.

    Article  PubMed  CAS  Google Scholar 

  9. Hebebrand J, Dempfle A, Saar K, et al.: A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatry 2006, 11:196–205.

    Article  PubMed  CAS  Google Scholar 

  10. Arcos-Burgos M, Castellanos FX, Pineda D, et al.: Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 2004, 75:998–1014.

    Article  PubMed  CAS  Google Scholar 

  11. Ogdie MN, Bakker SC, Fisher SE, et al.: Pooled genomewide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol Psychiatry 2006, 11:5–8.

    Article  PubMed  CAS  Google Scholar 

  12. Faraone SV, Khan SA: Candidate gene studies of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006, 67(Suppl 8):13–20.

    PubMed  CAS  Google Scholar 

  13. Asherson P, Brookes K, Franke B, et al.: Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 2007, 164:674–677.

    Article  PubMed  Google Scholar 

  14. Brookes KJ, Mill J, Guindalini C, et al.: A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 2006, 63:74–81.

    Article  PubMed  CAS  Google Scholar 

  15. Kereszturi E, Kiraly O, Csapo Z, et al.: Association between the 120-bp duplication of the dopamine D4 receptor gene and attention deficit hyperactivity disorder: genetic and molecular analyses. Am J Med Genet B Neuropsychiatr Genet 2007, 144:231–236.

    PubMed  Google Scholar 

  16. Xu X, Mill J, Zhou K, et al.: Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet B Neuropsychiatr Genet 2007, 144:83–86.

    PubMed  Google Scholar 

  17. Li J, Wang Y, Zhou R, et al.: Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 2007, 144:14–19.

    PubMed  Google Scholar 

  18. Li J, Wang Y, Zhou R, et al.: Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects. Neurosci Lett 2006, 407:107–111.

    Article  PubMed  CAS  Google Scholar 

  19. Deupree JD, Smith Sd, Kratochvil CJ, et al.: Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet 2006, 141:877–884.

    PubMed  CAS  Google Scholar 

  20. Brookes K, Xu X, Chen W, et al.: The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 2006, 11:934–953.

    Article  PubMed  CAS  Google Scholar 

  21. Weedon MN, Clark VJ, Qian Y, et al.: A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet 2006, 79:991–1001.

    Article  PubMed  CAS  Google Scholar 

  22. Duerr RH, Taylor KD, Brant SR, et al.: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461–1463.

    Article  PubMed  CAS  Google Scholar 

  23. Braun JM, Kahn RS, Froehlich T, et al.: Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006, 114:1904–1909.

    PubMed  Google Scholar 

  24. Ben Amor L, Grizenko N, Schwartz G, et al.: Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci 2005, 30:120–126.

    PubMed  Google Scholar 

  25. Neuman RJ, Lobos E, Reich W, et al.: Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry 2007, 61:1320–1328.

    Article  PubMed  CAS  Google Scholar 

  26. Knopik VS, Heath AC, Jacob T, et al.: Maternal alcohol use disorder and offspring ADHD: disentangling genetic and environmental effects using a children-of-twins design. Psychol Med 2006, 36:1461–1471.

    Article  PubMed  Google Scholar 

  27. Thapar A, Langley K, Fowler T, et al.: Catechol omethyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2005, 62:1275–1278.

    Article  PubMed  CAS  Google Scholar 

  28. Sengupta SM, Grizenko N, Schmitz N, et al.: COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J Am Acad Child Adolesc Psychiatry 2006, 45:1363–1369.

    Article  PubMed  Google Scholar 

  29. Kahn RS, Khoury J, Nichols WC, Lanphear BP: Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr 2003, 143:104–110.

    Article  PubMed  Google Scholar 

  30. Laucht M, Skowronek MH, Becker K, et al.: Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 2007, 64:585–590.

    Article  PubMed  CAS  Google Scholar 

  31. Andres RL, Day MC: Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000, 5:231–241.

    Article  PubMed  CAS  Google Scholar 

  32. Larsson JO, Larsson H, Lichtenstein P: Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. J Am Acad Child Adolesc Psychiatry 2004, 43:1267–1275

    Article  PubMed  Google Scholar 

  33. Larsson H, Lichtenstein P, Larsson JO: Genetic contributions to the development of ADHD subtypes from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 2006, 45:973–981.

    Article  PubMed  Google Scholar 

  34. Hay D, Bennett KS, McStephen M, et al.: Attention deficit-hyperactivity disorder in twins: a developmental genetic analysis. Aust J Psychol 2004, 56:99–107.

    Article  Google Scholar 

  35. Lahey BB, Pelham WE, Loney J, et al.: Instability of the DSM-IV subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry 2005, 62:896–902.

    Article  PubMed  Google Scholar 

  36. Croes EA, El Galta R, Houwing-Duistermaat JJ, et al.: Phenotypic subtypes in attention deficit hyperactivity disorder in an isolated population. Eur J Epidemiol 2005, 20:789–794.

    Article  PubMed  Google Scholar 

  37. Faraone SV, Biederman J, Friedman D: Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective. J Am Acad Child Adolesc Psychiatry 2000, 39:300–307.

    Article  PubMed  CAS  Google Scholar 

  38. de Graaf-Peters VB, Hadders-Algra M: Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 2006, 82:257–266.

    Article  PubMed  Google Scholar 

  39. Li J, Kang C, Wang Y, et al.: Contribution of 5-HT2A receptor gene-1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. Am J Med Genet B Neuropsychiatr Genet 2006, 141:473–476.

    PubMed  Google Scholar 

  40. El-Faddagh M, Laucht M, Maras A, et al.: Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J Neural Transm 2004, 111:883–889.

    Article  PubMed  CAS  Google Scholar 

  41. Barkley RA, Smith KM, Fischer M, Navia B: An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet 2006, 141:487–498.

    PubMed  Google Scholar 

  42. McGough J, McCracken J, Swanson J, et al.: Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006, 45:1314–1322.

    Article  PubMed  Google Scholar 

  43. Mick E, Biederman J, Spencer T, et al.: Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 2006, 141:890–894.

    PubMed  Google Scholar 

  44. Gainetdinov RR, Wetsel WC, Jones SR, et al.: Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397–401.

    Article  PubMed  CAS  Google Scholar 

  45. Levy F: What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications. Aust N Z J Psychiatry 2007, 41:10–16.

    Article  PubMed  Google Scholar 

  46. Mattay VS, Goldberg TE, Fera F, et al.: Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 2003, 100:6186–6191.

    Article  PubMed  CAS  Google Scholar 

  47. Krain AL, Castellanos FX: Brain development and ADHD. Clin Psychol Rev 2006, 26:433–444.

    PubMed  Google Scholar 

  48. Fan X, Hess EJ: D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. Neurobiol Dis 2007, 26:201–211.

    Article  PubMed  CAS  Google Scholar 

  49. Wang B, Wang Y, Zhou R, et al.: Possible association of the alpha-2A adrenergic receptor gene (ADR A2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2006, 141:130–134.

    PubMed  Google Scholar 

  50. Qian Q, Wang Y, Li J, et al.: Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 2007, 144:200–206.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josephine Elia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elia, J., Devoto, M. ADHD genetics: 2007 update. Curr Psychiatry Rep 9, 434–439 (2007). https://doi.org/10.1007/s11920-007-0057-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0057-z

Keywords

Navigation